Internal Medicine · Monterey, CA
NPI
1144227372
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5 Lower Ragsdale Dr Ste 100
Monterey, CA, 93940
Phone (831) 624-7070
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
8,371 services
Medicare patients, 2024
1,876
Average age 75
Drug cost, 2024
$1.0M
11,533 prescriptions
Company payments, 2025
$1,216
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca Abundis was code J0897 (injection, denosumab, 1 mg), 2,826 times for 43 patients. In total Rebecca Abundis billed 8,371 services in 55 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,826 | 43 | $20.51 | $58K |
| 36415 Venipuncture Blood Collection | Office | 2,503 | 1,457 | $8.64 | $22K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 599 | 599 | $45.01 | $27K |
| 99214 Office E&M - Established | Office | 597 | 430 | $46.76 | $28K |
| 99213 Office E&M - Established | Office | 493 | 376 | $44.30 | $22K |
| G0008 Administration of influenza virus vaccine | Office | 178 | 176 | $34.31 | $6,107 |
| 90662 Vaccine Product | Office | 172 | 171 | $81.42 | $14K |
| 96372 Injection Administration | Office | 150 | 78 | $10.85 | $1,628 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 75 | 18 | $0.89 | $67.12 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 68 | 68 | $72.07 | $4,901 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 55 | 48 | $62.70 | $3,449 |
| 81003 Clinical Chemistry | Office | 54 | 46 | $2.20 | $119 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 51 | 40 | $43.43 | $2,215 |
| 93000 Electrocardiogram | Office | 41 | 41 | $11.48 | $471 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 39 | 39 | $140.64 | $5,485 |
By year: 2022 $242K for 11,626 services; 2023 $219K for 9,629 services; 2024 $211K for 8,371 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,503 | 1,457 | $8.64 | $22K |
| 81003 Clinical Chemistry | 54 | 46 | $2.20 | $119 |
| 87428 Infectious Agent Detection by DNA/RNA | 23 | 20 | $65.53 | $1,507 |
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca Abundis prescribed most often to Medicare patients was Levothyroxine Sodium, with 784 prescriptions and refills. In total Rebecca Abundis wrote 11,533 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 784 | 2,104 | 196 | $11K |
| Atorvastatin Calcium Generic | 562 | 1,510 | 156 | $6,343 |
| Losartan Potassium Generic | 500 | 1,410 | 137 | $6,373 |
| Rosuvastatin Calcium Generic | 482 | 1,333 | 151 | $9,639 |
| Amlodipine Besylate Generic | 383 | 1,043 | 107 | $2,830 |
| Omeprazole Generic | 286 | 796 | 86 | $4,279 |
| Simvastatin Generic | 215 | 608 | 60 | $1,613 |
| Metoprolol Succinate Generic | 205 | 565 | 64 | $3,316 |
| Metformin Hcl Generic | 199 | 579 | 63 | $1,405 |
| Gabapentin Generic | 199 | 384 | 65 | $2,790 |
| Alprazolam Generic | 188 | 214 | 39 | $774 |
| Ezetimibe Generic | 167 | 446 | 53 | $5,591 |
| Furosemide Generic | 158 | 324 | 41 | $827 |
| Montelukast Sodium Generic | 155 | 353 | 41 | $2,055 |
| Escitalopram Oxalate Generic | 155 | 398 | 50 | $2,672 |
Brand drugs: 1,194 claims; generic drugs: 10,294 claims; opioid claims: 245.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca Abundis $1,216 ($1,216 in general payments such as food, travel and fees) from 19 companies. The largest payer was Pfizer Inc. with $189.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 11 | $189 |
| Abbvie Inc. ABBV | 13 | $172 |
| Merck Sharp & Dohme LLC MRK | 5 | $144 |
| GlaxoSmithKline, LLC. GSK | 5 | $104 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $88.65 |
| Amgen Inc. AMGN | 3 | $78.69 |
| Axsome Therapeutics, Inc. AXSM | 4 | $75.71 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $64.89 |
| Novo Nordisk Inc NVO | 2 | $46.9 |
| Lilly USA, LLC LLY | 2 | $46.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.